Phibro Animal Health (NASDAQ: PAHC) reported Q4 EPS of $0.41, $0.08 better than the analyst estimate of $0.33. Revenue for the quarter came in at $273.2 million versus the consensus estimate of $260.49 million.

GUIDANCE:

Phibro Animal Health sees FY2025 EPS of $1.22-$1.37, versus the consensus of $1.24. Phibro Animal Health sees FY2025 revenue of $1.04-1.09 billion, versus the consensus of $1.029 billion.

For earnings history and earnings-related data on Phibro Animal Health (PAHC) click here.